Article metrics

Original research
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression

 

Online download statistics by month:

Online download statistics by month: October 2022 to December 2022

AbstractFullPdf
Sep 202211761197331
Oct 2022560569158
Nov 2022399400248
Dec 2022263268105
Total23982434842